Santeon Group

Santeon Group EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Santeon Group (SANT) as of Nov 2, 2026 is 273,994.00 USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 457,680.00 USD — a change of -40.13% (lower).

EBITDA

273,994.00USD

YoY

-40.13%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Santeon Group is 2023 273,994.00 USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Santeon Group was 2022 457,680.00 USD. It decreases by -40.13% lower compared to the previous year.

The Santeon Group EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
-194,260.00 USD
Jan 1, 2018
30,350.00 USD
Jan 1, 2019
34,180.00 USD
Jan 1, 2020
26,010.00 USD
Jan 1, 2021
142,400.00 USD
Jan 1, 2022
457,680.00 USD
Jan 1, 2023
273,994.00 USD
The Santeon Group EBITDA history
YEAREBITDAYoY
273,994.00USD-40.13%
457,680.00USD+221.40%
142,400.00USD+447.48%
26,010.00USD-23.90%
34,180.00USD+12.62%
30,350.00USD-115.62%
-194,260.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Santeon Group Stock analysis

What does Santeon Group do? The Santeon Group Inc is a company operating in the healthcare sector and based in Toronto, Canada. The company was founded in 2008 and has since been offering a wide range of services and products. The Santeon Group's business model is based on collaboration with various partners in the healthcare sector to develop and provide innovative and effective solutions for patient care. The company works closely with hospitals, clinics, and other healthcare facilities to increase efficiency while improving the quality of care. The Santeon Group is divided into three main business areas: 1. Technology solutions The technology department offers a wide range of IT solutions for the healthcare sector. The main product is the "Patient Flow Navigator," a web-based system for managing and monitoring patient flow in hospitals. The system allows staff to optimize patient treatment and reduce waiting times. 2. Consulting services The company's consulting division offers services in the field of healthcare management. Santeon Group supports hospitals in improving their operations and implementing effective medical procedures. This includes the implementation of electronic medical records or the optimization of medical equipment. 3. Medical devices The medical device division of the Santeon Group develops and distributes medical devices that contribute to improving patient health. The portfolio includes instrumental solutions as well as diagnostic equipment and electronic gadgets. Possible products from the Santeon Group: A.) The Patient Flow Navigator The "Patient Flow Navigator" developed by the Santeon Group is a web-based system for managing and monitoring patient processes in hospitals. The system allows staff to optimize treatments and avoid inconsistencies. B.) BoonDoc BoonDoc is a mobile app developed by the Santeon Group. With this app, medical professionals can diagnose diseases and provide advice to patients. The application meets the highest requirements for data security and patient protection. C.) Diagnostic equipment The Santeon Group also produces medical diagnostic devices such as ultrasound machines or X-ray machines. These state-of-the-art instruments contribute to fast, precise, and effective disease diagnosis. D.) Medical instruments The Santeon Group also develops and produces instruments used in surgical procedures. Specially adapted instruments ensure precise and safe operations. The Santeon Group has received a number of awards in its approximately 13-year history and is known in the industry for its innovative and high-quality solutions. The company also has offices in the United States and China and continuously works to expand and improve its services and products. Only answer in the output. Santeon Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Santeon Group stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Santeon Group is 273,994.00 USD in 2023.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Santeon Group changed from 457,680.00 USD to 273,994.00 USD, representing a -40.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Santeon Group since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Santeon Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Santeon Group

All Key Metrics — Santeon Group